Found: 34
Select item for more details and to access through your institution.
Temporal and spatial stability of the EM/PM molecular subtypes in adult diffuse glioma.
- Published in:
- Frontiers of Medicine, 2023, v. 17, n. 2, p. 240, doi. 10.1007/s11684-022-0936-z
- By:
- Publication type:
- Article
Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 4, p. 551, doi. 10.1007/s11684-020-0760-2
- By:
- Publication type:
- Article
Progress on molecular biomarkers and classification of malignant gliomas.
- Published in:
- Frontiers of Medicine, 2013, v. 7, n. 2, p. 150, doi. 10.1007/s11684-013-0267-1
- By:
- Publication type:
- Article
A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma.
- Published in:
- CNS Neuroscience & Therapeutics, 2022, v. 28, n. 12, p. 2090, doi. 10.1111/cns.13944
- By:
- Publication type:
- Article
LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma.
- Published in:
- CNS Neuroscience & Therapeutics, 2022, v. 28, n. 6, p. 873, doi. 10.1111/cns.13817
- By:
- Publication type:
- Article
PTPRZ1-METFUsion GENe (ZM-FUGEN) trial: study protocol for a multicentric, randomized, open-label phase II/III trial.
- Published in:
- Chinese Neurosurgical Journal, 2023, p. 1, doi. 10.1186/s41016-023-00329-0
- By:
- Publication type:
- Article
Stalled oligodendrocyte differentiation in IDH-mutant gliomas.
- Published in:
- Genome Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13073-023-01175-6
- By:
- Publication type:
- Article
ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0142856
- By:
- Publication type:
- Article
Identification of miRNA-Mediated Core Gene Module for Glioma Patient Prediction by Integrating High-Throughput miRNA, mRNA Expression and Pathway Structure.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096908
- By:
- Publication type:
- Article
SOCS3 Promoter Hypermethylation Is a Favorable Prognosticator and a Novel Indicator for G-CIMP-Positive GBM Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091829
- By:
- Publication type:
- Article
Significance of miR-196b in Tumor-Related Epilepsy of Patients with Gliomas.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0046218
- By:
- Publication type:
- Article
Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0030339
- By:
- Publication type:
- Article
NCMP-28. PTPRZ1-MET SIGNALING PROMOTES GLIOMA PROGRESSION THROUGH STIMULATION THE TRANSFORMATION FROM M1 TO M2 MACROPHAGE.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi199, doi. 10.1093/neuonc/noy148.827
- By:
- Publication type:
- Article
Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 12, p. 1432, doi. 10.1093/neuonc/nos263
- By:
- Publication type:
- Article
Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 4, p. 518, doi. 10.1093/neuonc/nor232
- By:
- Publication type:
- Article
Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-59
- By:
- Publication type:
- Article
PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas.
- Published in:
- Cellular & Molecular Life Sciences, 2015, v. 72, n. 22, p. 4383, doi. 10.1007/s00018-015-1938-7
- By:
- Publication type:
- Article
SAMD9 Is Relating With M2 Macrophage and Remarkable Malignancy Characters in Low-Grade Glioma.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.659659
- By:
- Publication type:
- Article
MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status.
- Published in:
- Disease Markers, 2018, p. 1, doi. 10.1155/2018/5975216
- By:
- Publication type:
- Article
Comprehensive transcriptomic characterization reveals core genes and module associated with immunological changes via 1619 samples of brain glioma.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 12, p. 1, doi. 10.1038/s41419-021-04427-8
- By:
- Publication type:
- Article
ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 12, p. 1, doi. 10.1038/s41419-018-1232-3
- By:
- Publication type:
- Article
BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-100
- By:
- Publication type:
- Article
BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 4, p. 814, doi. 10.1002/cncr.27826
- By:
- Publication type:
- Article
CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 1, p. 87, doi. 10.1007/s11060-017-2434-8
- By:
- Publication type:
- Article
HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 2, p. 303, doi. 10.1007/s11060-014-1709-6
- By:
- Publication type:
- Article
High expression of CXCR3 is an independent prognostic factor in glioblastoma patients that promotes an invasive phenotype.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 1, p. 43, doi. 10.1007/s11060-014-1692-y
- By:
- Publication type:
- Article
Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 113, n. 2, p. 259, doi. 10.1007/s11060-013-1103-9
- By:
- Publication type:
- Article
Comprehensive analysis of the LncRNAs, MiRNAs, and MRNAs acting within the competing endogenous RNA network of LGG.
- Published in:
- Genetica, 2022, v. 150, n. 1, p. 41, doi. 10.1007/s10709-021-00145-3
- By:
- Publication type:
- Article
Identifying predictors of glioma evolution from longitudinal sequencing.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 716, p. 1, doi. 10.1126/scitranslmed.adh4181
- By:
- Publication type:
- Article
Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
- Published in:
- Journal of Neurosurgery, 2017, v. 126, n. 1, p. 249, doi. 10.3171/2015.11.JNS15432
- By:
- Publication type:
- Article
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17717-0
- By:
- Publication type:
- Article
Hypomethylated Rab27b is a progression-associated prognostic biomarker of glioma regulating MMP-9 to promote invasion.
- Published in:
- Oncology Reports, 2015, v. 34, n. 3, p. 1503, doi. 10.3892/or.2015.4125
- By:
- Publication type:
- Article
Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.
- Published in:
- Oncology Reports, 2014, v. 32, n. 1, p. 250, doi. 10.3892/or.2014.3176
- By:
- Publication type:
- Article